SMARCA2 and lung cancer: Among tumors with SWI/SNF chromatin remodeling abnormalities, loss of SMARCA4 and SMARCA2 protein expression has been shown to be a poor prognostic factor, particularly in lung cancer (Reisman et al. 2003).